Showing results (361-370 of 397) with videos related to

Sort By:
Pageof 40
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 4, 2024
Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY StudiesStacie Hudgens, Srdan Verstovsek, Lysbeth Floden, et al.
Hemasphere|October 30, 2023
Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM StudyRuben A Mesa, Claire Harrison, Jeanne M Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Perturbation of fetal liver hematopoietic stem and progenitor cell development by trisomy 21Anindita Roy, Gillian Cowan, Adam J Mead, et al.
Blood Advances|April 29, 2026
The lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat in myelofibrosis: results from a phase 1/2 studyHarinder Gill, Abdulraheem Yacoub, Aaron T Gerds, et al.
Blood|March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AMLZhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Science Translational Medicine|March 1, 2023
A cell-penetrant peptide blocking C9ORF72-repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteinsLydia M Castelli, Ya-Hui Lin, Alvaro Sanchez-Martinez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2023
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve MyelofibrosisJohn Mascarenhas, Marina Kremyanskaya, Andrea Patriarca, et al.
Cancer Research|November 3, 2023
Erythroid Differentiation Enhances RNA Mis-Splicing in SF3B1-Mutant Myelodysplastic Syndromes with Ring SideroblastsPedro L Moura, Teresa Mortera-Blanco, Isabel J Hofman, et al.
Blood|January 18, 2018
Canonical Notch signaling is dispensable for adult steady-state and stress myelo-erythropoiesisSara Duarte, Petter S Woll, Natalija Buza-Vidas, et al.
Cell Stem Cell|February 24, 2026
comBO: A combined human bone and lympho-myeloid bone marrow organoid for preclinical modeling of hematopoietic disordersYuqi Shen, Camelia Benlabiod, Edmund Watson, et al.
Pageof 40